Literature DB >> 9209353

Cooperating events in lymphomagenesis mediated by feline leukemia virus.

L S Levy1, C R Starkey, S Prabhu, P A Lobelle-Rich.   

Abstract

Feline leukemia virus (FeLV)-mediated lymphomagenesis in the domestic cat has been examined as a model of lymphoid malignancy in a naturally outbreeding population. The pathogenesis of two distinct, naturally occurring types of FeLV-induced tumors has been investigated: (1) a thymic lymphoma of T-cell origin, typical of FeLV-induced lymphoma, and (2) an extrathymic, extranodal lymphoma of non-B non-T-cell origin. The genetic features of these tumors are clearly distinguishable, and include determinants encoded both by the virus and the host. Virally encoded determinants of pathogenesis include the long terminal repeat (LTR) and the envelope SU protein. Cellular determinants include the involvement of a set of proto-oncogenes, and other factors characteristic of the specific cell type of origin of the tumor. Functional studies are aimed at evaluating the action and interaction of these genetic determinants in the pathogenesis of lymphoma in an animal model system.

Entities:  

Mesh:

Year:  1997        PMID: 9209353

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

Review 1.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

2.  Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Authors:  Willie M Greggs; Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  Ther Clin Risk Manag       Date:  2011-03-16       Impact factor: 2.423

Review 3.  Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort.

Authors:  Lisa L Bolin; Laura S Levy
Journal:  Viruses       Date:  2011-09-09       Impact factor: 5.048

4.  Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR.

Authors:  Samantha L Finstad; Sudha Prabhu; Karen R Rulli; Laura S Levy
Journal:  Virol J       Date:  2004-09-03       Impact factor: 4.099

5.  High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings.

Authors:  M Suntz; K Failing; W Hecht; D Schwartz; M Reinacher
Journal:  Vet Immunol Immunopathol       Date:  2010-03-25       Impact factor: 2.046

Review 6.  Transposons for cancer gene discovery: Sleeping Beauty and beyond.

Authors:  Lara S Collier; David A Largaespada
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.